Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 7,678,446 |
|
|||||
| News | - | ||||||
| Day High | 0.1433 | Low High |
|||||
| Day Low | 0.111 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kintara Therapeutics Inc | KTRA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0189 | 16.54% | 0.1332 | 19:56:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1141 | 0.111 | 0.1433 | 0.1327 | 0.1143 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,931 | 7,678,446 | $ 0.1291848 | $ 991,939 | - | 0.081 - 5.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:37 | formt | 500 | $ 0.1332 | USD |
Kintara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.07M | 39.04M | - | 0 | -15.02M | -0.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kintara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KTRA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1096 | 0.1433 | 0.101 | 0.114343 | 3,118,102 | 0.0236 | 21.53% |
| 1 Month | 0.0897 | 0.24 | 0.086 | 0.1483543 | 18,122,618 | 0.0435 | 48.49% |
| 3 Months | 0.124 | 0.24 | 0.081 | 0.1254488 | 14,489,155 | 0.0092 | 7.42% |
| 6 Months | 4.15 | 4.48 | 0.081 | 0.1444636 | 9,654,953 | -4.02 | -96.79% |
| 1 Year | 3.27 | 5.98 | 0.081 | 0.1848888 | 4,896,883 | -3.14 | -95.93% |
| 3 Years | 70.50 | 142.50 | 0.081 | 10.57 | 2,673,931 | -70.37 | -99.81% |
| 5 Years | 60.50 | 167.50 | 0.081 | 15.08 | 2,300,681 | -60.37 | -99.78% |
Kintara Therapeutics Description
| Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. |
